Pfizer Appoints Cecile Guegan Interim CFO As Dave Denton Departs

Pfizer said Chief Financial Officer Dave Denton will depart on August 15 to pursue an opportunity outside the pharmaceutical industry in consumer goods. The announcement is a routine management change with no financial metrics, guidance update, or operational impact disclosed. Investor impact is likely minimal.

Analysis

Pfizer said Chief Financial Officer Dave Denton will depart on August 15 to pursue an opportunity outside the pharmaceutical industry in consumer goods. The announcement is a routine management change with no financial metrics, guidance update, or operational impact disclosed. Investor impact is likely minimal.